Antiphospholipid syndrome and cancer
Antiphospholipid antibodies syndrome (APS) is an acquired prothrombotic status, that is due to the occurrence of a certain type of autoantibodies directed against negatively charged phospholipid structures – hence the name. Neoplasia is also characterized by a systemic procoagulant status, through v...
Main Author: | Razvan Adrian Ionescu |
---|---|
Format: | Article |
Language: | English |
Published: |
Amaltea Medical Publishing House
2021-03-01
|
Series: | Romanian Journal of Rheumatology |
Subjects: | |
Online Access: | https://rjr.com.ro/articles/2021.1/RJR_2021_1_Art-02.pdf |
Similar Items
-
Criteria and Non-Criteria Antiphospholipid Antibodies in Antiphospholipid Syndrome: How Strong Are They Correlated?
by: Simona Caraiola, et al.
Published: (2023-08-01) -
Catastrophic Antiphospholipid Syndrome
by: Victoria Bitsadze, et al.
Published: (2024-01-01) -
Differences in Antiphospholipid Antibody Profile between Patients with Obstetric and Thrombotic Antiphospholipid Syndrome
by: Ariadna Anunciación-Llunell, et al.
Published: (2022-10-01) -
Antiphospholipid Syndrome: To Classify or Not to Classify?
by: Doruk Erkan
Published: (2024-03-01) -
Portal thrombosis in antiphospholipid syndrome: Case report
by: Elkin J. Pelaes Cruz, et al.
Published: (2022-10-01)